<table border="1"><tr><th>Trade names</th><td>Risperdal, others</td></tr><tr><th>AHFS/Drugs.com</th><td>Monograph</td></tr><tr><th>MedlinePlus</th><td>a694015</td></tr><tr><th>License data</th><td>US |  DailyMed | Risperidone</td></tr><tr><th>Pregnancy | category</th><td>AU |  C</td></tr><tr><th>Routes of | administration</th><td>By mouth (tablets and liquid form), intramuscular injection</td></tr><tr><th>Drug class</th><td>Atypical antipsychotic</td></tr><tr><th>ATC code</th><td>N05AX08 ( | WHO | )</td></tr><tr><th>Legal status</th><td>AU |  S4 (Prescription only) | CA | : ℞-only | UK |  POM (Prescription only) | US |  ℞-only</td></tr><tr><th>Bioavailability</th><td>70% (by mouth)</td></tr><tr><th>Metabolism</th><td>Liver (CYP2D6 mediated to 9-hydroxyrisperidone)</td></tr><tr><th>Elimination | half-life</th><td>20 hours (by mouth), 3–6 days (IM)</td></tr><tr><th>Excretion</th><td>Urinary (70%) feces (14%)</td></tr><tr><th>Identifiers</th><td>IUPAC name | 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one</td></tr><tr><th>CAS Number</th><td>106266-06-2</td></tr><tr><th>PubChem | CID</th><td>5073</td></tr><tr><th>PubChem | SID</th><td>475100</td></tr><tr><th>IUPHAR/BPS</th><td>96</td></tr><tr><th>DrugBank</th><td>DB00734</td></tr><tr><th>ChemSpider</th><td>4895</td></tr><tr><th>UNII</th><td>L6UH7ZF8HC</td></tr><tr><th>KEGG</th><td>D00426</td></tr><tr><th>ChEBI</th><td>CHEBI:8871</td></tr><tr><th>ChEMBL</th><td>ChEMBL85</td></tr><tr><th>PDB ligand</th><td>8NU ( | PDBe | , | RCSB PDB | )</td></tr><tr><th>CompTox Dashboard | ( | EPA | )</th><td>DTXSID8045193</td></tr><tr><th>ECHA InfoCard</th><td>100.114.705</td></tr><tr><th>Formula</th><td>C | 23 | H | 27 | F | N | 4 | O | 2</td></tr><tr><th>Molar mass</th><td>410.493 |  g·mol | −1</td></tr><tr><th>3D model (JSmol)</th><td>Interactive image</td></tr></table>